What We Lose With Age is a key topic under Science And Technology for UPSC Civil Services Examination. Key points include: Cellular senescence (Hayflick Limit) dictates how many times cells divide, influencing species lifespan.. Telomeres are protective DNA caps on chromosomes that shorten with each cell division.. Critical telomere shortening signals cells to stop dividing, contributing to aging.. Understanding this topic is essential for both UPSC Prelims and Mains preparation.
What We Lose With Age is a Medium-level topic in UPSC Science And Technology. It is tested in both Prelims (factual MCQs) and Mains (analytical answer writing). Previous year UPSC questions have frequently covered aspects of What We Lose With Age, making it essential for comprehensive IAS preparation.
To prepare What We Lose With Age for UPSC: (1) Study the comprehensive notes covering all key concepts on Vaidra. (2) Practice previous year questions on this topic. (3) Connect it with current affairs using daily updates. (4) Revise using key takeaways and mind maps available for Science And Technology. (5) Write practice answers linking What We Lose With Age to related GS Paper topics.

The concept of cellular senescence, or the irreversible cessation of cell division, plays a crucial role in understanding the aging process across different species. This natural biological limit influences an organism's overall lifespan.
For instance, cells from Galapagos turtles, renowned for their longevity, can divide approximately 110 times before reaching senescence. This correlates with their remarkable lifespan of over 200 years.
In stark contrast, cells from typical laboratory mice become senescent after only about 15 divisions. This significantly lower number aligns with their much shorter lifespans.
Further scientific investigations in the 1970s led to a significant discovery: telomeres. These are specialized, repetitive sequences of Deoxyribonucleic acid (DNA) found at the very ends of chromosomes.
The primary function of telomeres is to protect the genetic information contained within chromosomes during the process of cell division. They act like caps, preventing the loss of vital DNA sequences.
However, with each successive round of cell division, telomeres progressively become shorter. This shortening continues until they reach a critical length, which then signals the cell to stop dividing.
This mechanism of telomere shortening is widely understood to be a significant contributor to the phenomenon of ageing and the eventual decline of cellular function.
While a clear link exists between telomere shortening and the process of ageing, the precise correlation between an organism's initial telomere length and its ultimate lifespan is not straightforward or absolute.
A notable example is the comparison between humans and mice. Despite having significantly longer telomeres than humans, mice exhibit considerably shorter lifespans. This suggests other complex factors are at play.
Some researchers propose that telomere loss and the Hayflick limit (the finite number of times a normal human cell population will divide in vitro) may not be direct causes of ageing. Instead, they might be considered symptoms or manifestations of the broader ageing process itself.
In the 1980s, scientists made another groundbreaking discovery: a protein called telomerase. This remarkable enzyme possesses the unique ability to produce new telomeres, effectively counteracting the shortening process.
Telomerase is notably active in cancer cells. Its presence allows these cells to bypass the natural Hayflick limit, enabling them to continue dividing indefinitely and contributing to uncontrolled growth.
As famously stated by Hayflick himself, this is precisely why cancer cells are not subject to the normal limitations imposed by the Hayflick Limit, allowing them to achieve immortality in a laboratory setting.
Despite its potential, the primary activity of telomerase in cancer cells presents significant challenges for its therapeutic application in healthy cells. Harnessing its power without risking cancerous growth is a major hurdle.
Although scientists have successfully synthesized telomerase in laboratories, and some in vitro studies have shown promise in slowing down telomere loss in normal human cells, practical application remains a distant goal.
Understanding the dual nature of telomerase – its role in both cancer and potential anti-aging therapies – is crucial for UPSC Mains GS Paper 3 questions on biotechnology and health research. Focus on the ethical and practical challenges.


PM Modi Calls for Austerity‑Style Behavioural Changes Amid Oil‑Price Shock – What It Means for India
4 Jun 2026
Watch: Karnataka CM change: Siddaramaiah resigns, what’s next? | Above the Fold | 28.05.2026
28 May 2026
Knowledge Nugget: What makes GalaxEye’s Drishti satellite first of its kind?
11 May 2026
What is Karnataka’s new gig worker grievance system? | Explained
7 May 2026